Drugs / Pueraria Mirifica
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06220266 | Mar → Aug 2024 | hyperlipidemia, hyperlipoproteinemia, hypertriglyceridemia, hypoalphalipoproteinemia | Dhurakij Pundit University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pueraria Mirifica | “The goal of this clinical trial is to learn about the effects of phytoestrogen from Pueraria Mirifica in improvement of serum lipid parameters.” NCT06220266 ↗ |